InspireMD Inc expected to post a loss of 15 cents a share - Earnings Preview

InspireMD

30/10/2026 14:26

InspireMD Inc NSPR.OQ NSPR.O is expected to  show a fall in quarterly revenue when it reports  results on November 12 for the period ending September 30 2026
The Miami Florida-based  company is expected to report a 20.9% decrease in revenue to $1.996 million from $2.52 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for InspireMD Inc is for a loss of 15 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for InspireMD Inc is $3.00, about 564.6% above its last closing price of $0.45
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2026
-0.20
-0.20
-0.17
Beat
15
Mar. 31 2026
-0.17
-0.18
-0.16
Beat
11.1
Dec. 31 2025
-0.18
-0.19
-0.14
Beat
27.6​
Sep. 30 2025
-0.19
-0.19
-0.17
Beat
12.8
​​Jun. 30 2025
-0.26
-0.26
-0.26
Met
0
Mar. 31 2025
-0.20
-0.20
-0.22
Missed
-10​
Dec. 31 2024
-0.19
-0.19
-0.19
Met
2.6
Sep. 30 2024
-0.20
-0.16
Beat
20
This summary was machine generated October 30 at 14:26 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)